Glita Tablet (Pioglitazone Hydrochloride)

Adult dose

This medication is taken orally once daily, regardless of meals. As monotherapy, it can be initiated at 15 mg once daily, and if the effect is insufficient, the dosage can be increased up to 30 mg once daily. In combination therapy, 15 mg once daily is also administered, and the maximum recommended dose should not exceed 30 mg once daily.

Child dose

There is no experience with use in patients under 18 years, so administration is not recommended.

This medication helps control blood sugar in patients with type 2 diabetes. It may cause or worsen congestive heart failure in some patients, so symptoms of heart failure, such as weight changes, shortness of breath, and edema, should be closely monitored after starting treatment or increasing doses. This drug should not be used in patients with heart failure or a history of heart failure, and its administration is not recommended in these patients. This medication may cause fluid retention, leading to worsened heart failure when used in combination with other diabetes treatments, so symptoms of heart failure should always be monitored closely. If symptoms such as visible hematuria, urinary issues, or urgent urination arise during the use of this drug, they may indicate bladder cancer, and a doctor should be notified immediately. This medication should not be administered to patients with impaired liver function, severe renal impairment, active bladder cancer, pregnant women, or women of childbearing potential. Patients taking other oral hypoglycemic agents, premenopausal women, patients with edema, patients with heart conditions, and those with kidney dysfunction should use this medication carefully. This drug may cause side effects such as edema, weight gain, headache, upper respiratory infection, and in patients with a history of heart disease, there is an increased risk of developing congestive heart failure. Liver function tests and blood sugar control status should be monitored regularly while on this medication, and hypoglycemic symptoms should be observed. The use of this drug is restricted during pregnancy, and the effects on breastfeeding mothers are not known, so caution is required. It should also be used carefully in the elderly, and appropriate treatment should be given in case of overdose depending on symptoms. The safety and efficacy of this drug in children have not been established.

Serious side effects

Congestive heart failure, signs and symptoms of heart failure (including excessive weight changes, shortness of breath, edema), serious heart failure, cardiac failure, myocardial infarction, stroke, urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe edema associated with increased blood pressure, bladder cancer, liver abnormalities (jaundice), fatal and non-fatal liver failure, suspected acute liver injury symptoms (fatigue, loss of appetite, discomfort in the right upper abdomen,

Mild side effects

• Headache
• sinusitis
• myalgia
• pharyngitis
• upper respiratory infection
• abdominal bloating
• weight gain
• hypoglycemia
• urinary tract infection
• diarrhea

This medication should be stored in a container that is well protected from light and air, and in a place that is not humid. The storage temperature should be maintained between 15 and 30 degrees Celsius, preferably around 25 degrees.

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle